Clinically Relevant Radioactive Dose Formulation of 177 Lu-Labeled Cetuximab-Fab Fragment for Potential Use in Cancer Theranostics

Rubel Chakravarty, Nanda Rohra, Sudipta Chakraborty, Ratnesh Jain, Haladhar Dev Sarma, Ashutosh Dash
  • ChemistrySelect, January 2018, Wiley
  • DOI: 10.1002/slct.201702224

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Haladhar Dev Sarma

In partnership with: